GlassScriptPhysician profile
Tommy L Miller
NPI 1679506547
$6,944.26
in general payments reported to CMS, 2019-2025
34 companies · $847 in 2025
The $847 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,093 · 2020: $409 · 2021: $449 · 2022: $1,118 · 2023: $1,347 · 2024: $1,682 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,038 · Travel and Lodging: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,038.18 |
| Travel and Lodging | $838.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $977.28 | 2019-2021 | |
| Abiomed | $902.09 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $845.45 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $538.17 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Latitude Communicator Power Supply |
| Novartis Pharmaceuticals Corporation | $484.07 | 2019-2025 | |
| Abbott Laboratories | $373.84 | 2019-2025 | Perclose Prostyle, Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral |
| Amgen INC. | $347.33 | 2021-2024 | Repatha |
| Medtronic, INC. | $271.41 | 2022-2025 | Corevalve Evolut R, Linq II |
| Merck Sharp & Dohme LLC | $256.32 | 2021-2023 | Verquvo, Belsomra |
| Janssen Pharmaceuticals, INC | $242.03 | 2019-2023 | Xarelto |
| Alnylam Pharmaceuticals INC. | $211.41 | 2022-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.97 | 2022-2024 | Jardiance |
| Pfizer INC. | $156.93 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $144.26 | 2021-2024 | Andexxa |
| Atricure, INC. | $143.06 | 2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $130.50 | 2022-2025 | Camzyos |
| Nuwellis, INC. | $122.05 | 2022-2023 | Aquadex Smartflow Console |
| Amarin Pharma, INC. | $85.80 | 2019 | |
| Irhythm Technologies, INC. | $84.06 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $81.37 | 2020-2024 | Rotarexs 6 F X 135 Cm |
| Medtronic Vascular, INC. | $78.71 | 2019 | |
| Vital Connect, INC | $35.31 | 2023 | Vitalpatch Rtm |
| Angiodynamics, INC. | $34.42 | 2021 | |
| Arbor Pharmaceuticals, INC. | $27.21 | 2019 | |
| Daxor Corporation | $25.52 | 2022 | |
| Edwards Lifesciences Corporation | $25.15 | 2019 | |
| Advanced Respiratory, INC | $21.24 | 2021 | |
| Inspire Medical Systems, INC. | $21.08 | 2025 | Inspire |
| Philips North America LLC | $19.35 | 2024 | (Ck4) Mcot |
| Biotronik INC. | $15.70 | 2019 | |
| Becton, Dickinson and Company | $15.62 | 2023 | Crosser Iq |
| Ge Healthcare | $14.79 | 2020 | |
| Scpharmaceuticals INC. | $14.24 | 2024 | |
| Cardinal Health 200 LLC | $13.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tommy Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.